
|Videos|August 7, 2021
Evaluating risuteganib for dry eye disease treatment
Author(s)David Hutton, Alex Delaney-Gesing
Advertisement
Eric Donnenfeld, MD, of Ophthalmic Consultants of Long Island (Garden City, NY), discusses highlights from his presentation of trial results analyzing risuteganib as a potential treatment for dry eye disease.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
STAAR Surgical terminates proposed acquisition by Alcon
2
FDA grants Breakthrough Therapy Designation to Oculis’ privosegtor for optic neuritis
3
Long-lived Greenland sharks may point to new approaches for retinal disease
4
IRIS Registry data mined for understanding of pediatric NK
5











































